Murata K, García-Sastre A, Tsuji M, Rodrigues M, Rodriguez D, Rodriguez J R, Nussenzweig R S, Palese P, Esteban M, Zavala F
Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, New York 10010, USA.
Cell Immunol. 1996 Oct 10;173(1):96-107. doi: 10.1006/cimm.1996.0255.
We characterized the in vivo primary and secondary murine CD8+ T cell responses induced by immunization with influenza and vaccinia viruses, which were engineered to express the same H-2K(k)- and H-2K(d)-restricted epitopes. Our results show that the induction and magnitude of the primary CD8+ T cell response closely depends on the viral dose used for immunization, while it is not affected by the route of immunization. The induction of secondary CD8+ T cell responses appears to be highly restricted, as suggested by the lack of in vivo expansion of antigen-specific CD8+ T cells after repeated immunization with the same virus. In contrast, a 20- to 30-fold increase in the frequency of antigen-specific CD8+ T cells could be induced after combined immunization with recombinant influenza and vaccinia viruses. These findings may provide the basis for the development of new prophylactic and therapeutic strategies to prevent or control intracellular infections and certain malignancies.
我们对用流感病毒和痘苗病毒免疫诱导的体内原发性和继发性小鼠CD8+ T细胞反应进行了表征,这些病毒经过基因工程改造以表达相同的H-2K(k)和H-2K(d)限制性表位。我们的结果表明,原发性CD8+ T细胞反应的诱导和强度密切依赖于用于免疫的病毒剂量,而不受免疫途径的影响。继发性CD8+ T细胞反应的诱导似乎受到高度限制,这从用同一病毒重复免疫后抗原特异性CD8+ T细胞在体内缺乏扩增可以看出。相反,用重组流感病毒和痘苗病毒联合免疫后,抗原特异性CD8+ T细胞的频率可增加20至30倍。这些发现可能为开发预防或控制细胞内感染和某些恶性肿瘤的新的预防和治疗策略提供基础。